【摘 要】
：
Aims:To investigate the prevalence of HBV in HIV-infected adults in Guangdong province and assess the frequency of lamivudine(3TC) resistance mutations in HIV/HBV co-infected patients treated with 3TC
【机 构】
：
Department of Infectious Diseases,Guangzhou No.8 People's Hospital,Guangzhou Medical University
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
论文部分内容阅读
Aims:To investigate the prevalence of HBV in HIV-infected adults in Guangdong province and assess the frequency of lamivudine(3TC) resistance mutations in HIV/HBV co-infected patients treated with 3TC-containing HAART.
其他文献
目的 观察甲基强的松龙冲击治疗儿童重症肌无力临床疗效.方法 32例重症肌无力患儿采用甲基强的松龙冲击治疗：使用甲基强的松龙20mg/kg冲击3天,后用强的松2mg/kg口服4天,以上为一疗程.共计2～3疗程.观察临床疗效.结果 肌无力症状改善20例,有效率87.0％.3例改善不明显,口服溴砒定斯的明后症状改善.2年后随访病人,症状消失21例,2例病情稳定无进展.结论 大剂量甲基强的松龙冲击治疗儿童
[目的]通过对学习障碍儿童视觉、听觉注意力干预探讨注意力改善对学习障碍(learning disabilities LD)儿童学习能力的影响。[方法]本实验研究分别对57例LD儿童采用循序渐进以及分级别化增加难度的视觉、听觉注意力训练干预实验3个疗程，同时应用持续注意力测试法、学习技能量表法及CONNERS父母症状问卷法对LD儿童训练前后视觉、听觉注意力缺损率、学习能力及行为能力的变化进行效果评价
目的 探讨血清胱抑素C(CystatinC,CysC),血、尿β2微球蛋白(β2-microglobulin β2-MG)和尿微白蛋白(microalbumin,MA)联合检测对过敏性紫癜早期肾损伤的诊断价值. 方法 选择82例在儿科病房住院的HSP患儿,分为普通组49例,肾型组33例,另随机选择同期门诊体检儿童58例为对照组,检测受试者血清胱抑素、尿微白蛋白、血和尿β2微球蛋白、血肌酐、血尿素的
We previously reported a proof-of-concept study for curing chronic hepatitis B virus(HBV)infection using a foreign-antigen recombinant HBV(rHBV) as a gene therapy vector.
Hepatitis B surface antigen(HBsAg) seroclearance rarely occurs in patients with chronic hepatitis B(CHB).The annual incidence of spontaneous HBsAg seroclerance is estimated to be approximately 0.1-0.8
1.Ontogenetic differences have genetic background?There may be individual genetic background whether hepatitis B aggravate.
Hepatic steatosis is a common feature in patients with chronic hepatitis C virus(HCV) infection.HCV core protein plays an important role in the development of hepatic steatosis in HCV infection.
Chronic infection with hepatitis B virus(HBV) contributes to more than three quarters of hepatocellular carcinoma(HCC) cases worldwide.It remains a great challenge to know how HBV causes HCC.
Background:Chronic hepatitis B virus(HBV) infection and subsequent chronic inflammation are major risk factors of hepatocellular carcinoma(HCC) in China.
Interferon-alfa(IFN-α) has dual mode of actions of inhibiting hepatitis B virus(HBV) DNA replication and modulating the host immune response against HBV.1 Pegylated formation of interferon-alfa(pegint